The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Christophe Louvet

Service d'Oncologie

Hôpital St-Antoine

184 rue du faubourg St-Antoine

75012 Paris

France

[email]@sat.ap-hop-paris.fr

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Service d'Oncologie, Hôpital St-Antoine, 184 rue du faubourg St-Antoine, 75012 Paris, France. 2003 - 2005
  • Hôpital St-Antoine, Service de Medecine Int-Onc, Paris, France. 2004
  • Service d'Oncologie-Médecine Interne, Hôpital Saint-Antoine, Service d'Oncologie, Hôpital Tenon, France. 2002 - 2003
  • INSERM Unit 482, Hôpital St-Antoine, Paris, France. 2000 - 2001

References

  1. Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial. Louvet, C., Labianca, R., Hammel, P., Lledo, G., Zampino, M.G., André, T., Zaniboni, A., Ducreux, M., Aitini, E., Taïeb, J., Faroux, R., Lepere, C., de Gramont, A. J. Clin. Oncol. (2005) [Pubmed]
  2. Pemetrexed in advanced colorectal cancer. Louvet, C., de Gramont, A. Oncology (Williston Park, N.Y.) (2004) [Pubmed]
  3. Prognostic factor analysis in advanced gastric cancer patients treated with hydroxyurea, leucovorin, 5-fluorouracil, and cisplatin (HLFP regimen). Louvet, C., Carrat, F., Mal, F., Mabro, M., Beerblock, K., Vaillant, J.C., Cady, J., André, T., Gamelin, E., de Gramont, A. Cancer Invest. (2003) [Pubmed]
  4. Colorectal cancer: integrating oxaliplatin. Louvet, C., de Gramont, A. Curr. Treat. Options. Oncol (2003) [Pubmed]
  5. Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study. Louvet, C., André, T., Lledo, G., Hammel, P., Bleiberg, H., Bouleuc, C., Gamelin, E., Flesch, M., Cvitkovic, E., de Gramont, A. J. Clin. Oncol. (2002) [Pubmed]
  6. Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. Louvet, C., André, T., Tigaud, J.M., Gamelin, E., Douillard, J.Y., Brunet, R., François, E., Jacob, J.H., Levoir, D., Taamma, A., Rougier, P., Cvitkovic, E., de Gramont, A. J. Clin. Oncol. (2002) [Pubmed]
  7. Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM). Louvet, C., André, T., Hammel, P., Selle, F., Landi, B., Cattan, S., Fonck, M., Flesch, M., Colin, P., Balosso, J., Ruszniewski, P., de Gramont, A. Ann. Oncol. (2001) [Pubmed]
  8. Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice. Louvet, C., Coudray, A.M., Tournigand, C., Prévost, S., Raymond, E., de Gramont, A., Chazard, M., Gespach, C. Anticancer. Drugs (2000) [Pubmed]
 
WikiGenes - Universities